$HNOI
HNO International, Inc. Stock $hnoi

$hnoi Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000126246324000034 Filed on March 18, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$0.00	$13.00K
YoY Change	-100.0%
Cost Of Revenue
YoY Change
Gross Profit	$0.00	$13.00K
YoY Change	-100.0%
Gross Profit Margin		100.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$32.25K	$792.00
YoY Change	3971.46%
% of Gross Profit		6.09%
Operating Expenses	$523.1K	$217.4K
YoY Change	140.64%
Operating Profit	-$522.7K	-$204.4K
YoY Change	155.76%
Interest Expense	$6.932K	$6.052K
YoY Change	14.54%
% of Operating Profit
Other Income/Expense, Net	$367.00	$2.00
YoY Change	18250.0%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	-$522.7K	-$204.4K
YoY Change	155.76%
Net Earnings / Revenue		-1572.11%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	419.4M shares	166.1M shares
Diluted Shares Outstanding	419.4M shares	166.1M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$68.87K	$124.1K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$125.3K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$866.1K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$136.7K
YoY Change
Total Long-Term Assets	$1.081M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$125.3K
Total Long-Term Assets	$1.081M
Total Assets	$1.206M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.144K
YoY Change
Accrued Expenses	$48.20K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.106M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.106M
Total Long-Term Liabilities
Total Liabilities	$1.696M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$42.13M
YoY Change
Common Stock	$41.59M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$489.4K	-$928.3K
YoY Change
Total Liabilities & Shareholders Equity	$1.206M
YoY Change

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$522.7K	-$204.4K
YoY Change	155.76%
Depreciation, Depletion And Amortization	$32.25K	$792.00
YoY Change	3971.46%
Cash From Operating Activities	-$394.1K	-$188.6K
YoY Change	108.94%
INVESTING ACTIVITIES
Capital Expenditures	$130.4K	$20.38K
YoY Change	539.8%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$163.3K	-$20.38K
YoY Change	701.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$182.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$391.1K	$282.0K
YoY Change	38.68%
NET CHANGE
Cash From Operating Activities	-$394.1K	-$188.6K
Cash From Investing Activities	-$163.3K	-$20.38K
Cash From Financing Activities	$391.1K	$282.0K
Net Change In Cash	-$166.3K	$73.01K
YoY Change	-327.77%
FREE CASH FLOW
Cash From Operating Activities	-$394.1K	-$188.6K
Capital Expenditures	$130.4K	$20.38K
Free Cash Flow	-$524.5K	-$209.0K
YoY Change	150.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-31
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001342916
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-01-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-56568
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	HNO INTERNATIONAL, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-2781289
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	41558 Eastman Drive
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite B
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Murrieta
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92562
CY2024Q1	dei	City Area Code CityAreaCode	951
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	305-8872
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	419485085	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68869	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	235159	usd
CY2024Q1	hnoi	Due From Related Party DueFromRelatedParty	56392	usd
CY2023Q4	hnoi	Due From Related Party DueFromRelatedParty	56392	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	125261	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	291551	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	866077	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	767938	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	78287	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	79324	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	136725	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	103821	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	0	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	100000	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1081089	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1051083	usd
CY2024Q1	us-gaap	Assets Assets	1206350	usd
CY2023Q4	us-gaap	Assets Assets	1342634	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4144	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	925	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	48201	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41270	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2838	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17640	usd
CY2024Q1	hnoi	Advances Related Party AdvancesRelatedParty	265585	usd
CY2023Q4	hnoi	Advances Related Party AdvancesRelatedParty	0	usd
CY2024Q1	hnoi	Notes Payable Related Party Current NotesPayableRelatedPartyCurrent	785000	usd
CY2023Q4	hnoi	Notes Payable Related Party Current NotesPayableRelatedPartyCurrent	785000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1105768	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	844835	usd
CY2024Q1	hnoi	Long Term Notes Payable Related Party LongTermNotesPayableRelatedParty	590000	usd
CY2023Q4	hnoi	Long Term Notes Payable Related Party LongTermNotesPayableRelatedParty	590000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1695768	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1434835	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	985000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	985000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	419433085	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	419433085	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	419341584	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	419341584	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	419433	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	419341	usd
CY2024Q1	hnoi	Common Stock Payable CommonStockPayable	66250	usd
CY2023Q4	hnoi	Common Stock Payable CommonStockPayable	32251	usd
CY2024Q1	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	23750	usd
CY2023Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	23750	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	41171311	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	41079902	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-42132662	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41609945	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-489418	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-92201	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1206350	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1342634	usd
CY2024Q1	us-gaap	Revenues Revenues	0	usd
CY2023Q1	us-gaap	Revenues Revenues	13000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	0	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	13000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2025	usd
CY2024Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	0	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	3000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	219207	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	109247	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	33283	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	883	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3790	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1090	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	6932	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	6052	usd
CY2024Q1	hnoi	Legal And Accounting Fees LegalAndAccountingFees	122473	usd
CY2023Q1	hnoi	Legal And Accounting Fees LegalAndAccountingFees	26551	usd
CY2024Q1	hnoi	Meals Expenses MealsExpenses	45	usd
CY2023Q1	hnoi	Meals Expenses MealsExpenses	0	usd
CY2024Q1	hnoi	Office Expenses OfficeExpenses	2005	usd
CY2023Q1	hnoi	Office Expenses OfficeExpenses	456	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	22655	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	23250	usd
CY2024Q1	us-gaap	Salaries And Wages SalariesAndWages	89343	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	28717	usd
CY2024Q1	hnoi	Rental Expense RentalExpense	15561	usd
CY2023Q1	hnoi	Rental Expense RentalExpense	15166	usd
CY2024Q1	hnoi	Security Service SecurityService	213	usd
CY2023Q1	hnoi	Security Service SecurityService	0	usd
CY2024Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	5901	usd
CY2023Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	91	usd
CY2024Q1	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	1618	usd
CY2023Q1	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	847	usd
CY2024Q1	hnoi	Vehicle Expenses VehicleExpenses	59	usd
CY2023Q1	hnoi	Vehicle Expenses VehicleExpenses	0	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	523084	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	217376	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	367	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	2	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	367	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-522717	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-204374	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-522717	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-204374	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	419389590	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	419389590	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	166121006	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	166121006	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1110424	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	182000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2025	usd
CY2023Q1	hnoi	Common Stock Issued For Settlement Of Debt CommonStockIssuedForSettlementOfDebt	20000	usd
CY2023Q1	hnoi	Common Stock To Be Issued From Cash Proceeds CommonStockToBeIssuedFromCashProceeds	100000	usd
CY2023Q1	hnoi	Series Preferred Issued Pursuant To Patent Agreement SeriesPreferredIssuedPursuantToPatentAgreement	82500	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-204374	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-928273	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-92201	usd
CY2024Q1	hnoi	Regulation Common Stock Issuances RegulationCommonStockIssuances	125500	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-522717	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-489418	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-522717	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-204374	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	33283	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	883	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2025	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3219	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	usd
CY2024Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	100000	usd
CY2023Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	6800	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	6931	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	6052	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-14802	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-394086	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-188614	usd
CY2024Q1	hnoi	Proceeds From Related Party Advances ProceedsFromRelatedPartyAdvances	265585	usd
CY2023Q1	hnoi	Proceeds From Related Party Advances ProceedsFromRelatedPartyAdvances	0	usd
CY2024Q1	hnoi	Proceeds From Sale Of Common Stock Subscription Payable ProceedsFromSaleOfCommonStockSubscriptionPayable	33999	usd
CY2023Q1	hnoi	Proceeds From Sale Of Common Stock Subscription Payable ProceedsFromSaleOfCommonStockSubscriptionPayable	100000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	91501	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	182000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	391085	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	282000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	130385	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20379	usd
CY2024Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	32904	usd
CY2023Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	-0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-163289	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20379	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-166290	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	73007	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	235159	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51109	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68869	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	124116	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q1	hnoi	Series Preferred Stock Issued Pursuant To Patent Agreement SeriesPreferredStockIssuedPursuantToPatentAgreement	0	usd
CY2023Q1	hnoi	Series Preferred Stock Issued Pursuant To Patent Agreement SeriesPreferredStockIssuedPursuantToPatentAgreement	82500	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	20000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zQFQYHjmZCe9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_864_zJAMP7F3lGe3">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the condensed financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amount of revenues and expenses during the reporting period. The management makes its best estimate of the outcome for these items based on information available when the condensed financial statements are prepared.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-42132662	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	935263	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	804878	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	69186	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36940	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	866077	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	767938	usd
CY2024Q1	us-gaap	Depreciation Depreciation	32246	usd
CY2023Q1	us-gaap	Depreciation Depreciation	792	usd
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2024Q1	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	82500	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	82500	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4312	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3176	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	78287	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	79324	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1037	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	91	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	985000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	510000000	shares
CY2023Q1	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	1000000000	shares
CY2023Q3	hnoi	Stock Issued During Period Regulation A Stock Issuances Shares StockIssuedDuringPeriodRegulationAStockIssuancesShares	1968032	shares
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.00
CY2023Q3	hnoi	Stock Issued During Period Regulation A Stock Issuance StockIssuedDuringPeriodRegulationAStockIssuance	1968032	usd
CY2023Q4	hnoi	Stock Issued During Period Regulation A Stock Issuances Shares StockIssuedDuringPeriodRegulationAStockIssuancesShares	58500	shares
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.00
CY2023Q4	hnoi	Stock Issued During Period Regulation A Stock Issuance StockIssuedDuringPeriodRegulationAStockIssuance	58500	usd
CY2024Q1	hnoi	Stock Issued During Period Regulation A Stock Issuances Shares StockIssuedDuringPeriodRegulationAStockIssuancesShares	91501	shares
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.00
CY2024Q1	hnoi	Stock Issued During Period Regulation A Stock Issuance StockIssuedDuringPeriodRegulationAStockIssuance	91501	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	419433085	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	419341584	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	1375000	usd
CY2023Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	1375000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	48201	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41270	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	136725	usd

Files In Submission

Name	View Source	Status
0001262463-24-000034-index-headers.html	Edgar Link	pending
0001262463-24-000034-index.html	Edgar Link	pending
0001262463-24-000034.txt	Edgar Link	pending
0001262463-24-000034-xbrl.zip	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hnoi-20240131.xsd	Edgar Link	pending
hnoi013124q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
hnoi-20240131_cal.xml	Edgar Link	unprocessable
hnoi-20240131_def.xml	Edgar Link	unprocessable
hnoi-20240131_lab.xml	Edgar Link	unprocessable
hnoi-20240131_pre.xml	Edgar Link	unprocessable
hnoi013124q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HNOI
HNO International, Inc. Stock $hnoi

2024 Q1 Form 10-Q Financial Statement

#000126246324000034 Filed on March 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HNOI HNO International, Inc. Stock $hnoi

2024 Q1 Form 10-Q Financial Statement

#000126246324000034 Filed on March 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HNOI
HNO International, Inc. Stock $hnoi